Pillstats
Rx only · Capsule, Extended Release · Oral

Memantine Hydrochloride

Memantine Hydrochloride

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US35 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06DX01
RxCUI (US)6719
US makers10 labelers
Packages71
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 36 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.114$0.228$0.341$0.455Dec 2025Apr 2026Jul 2026
$0.359
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
9
Active US suppliers
34%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.5K3.1K4.6K6.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.4K
Rx · 2026 Q1
160K
Units dispensed
-8%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown12SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown12SUPPLYING
Zydus Lifesciences Limitedunknown12SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
Macleods Pharmaceuticals Limitedunknown8SUPPLYING
Slate Run Pharmaceuticals, LLCunknown6SUPPLYING
Lupin Pharmaceuticals,Inc.unknown6SUPPLYING
Vitruvias Therapeuticsunknown4SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown1EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 24, 2026
    RECALLRecall (Class II): Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and D…

    Failed Dissolution Specifications — Recalling firm: The Harvard Drug Group LLC — US Nationwide.

  • Apr 24, 2020
    RECALLRecall (Class III): Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by:…

    Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing. — Recalling firm: The Harvard Drug Group — AL, FL, IA, NY, OH, TX

  • Feb 12, 2020
    RECALLRecall (Class II): Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceut…

    Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States.

  • Dec 13, 2019
    RECALLRecall (Class III): Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufacture…

    Failed Dissolution Specifications: High out of specification result observed at stability studies. — Recalling firm: The Harvard Drug Group — U.S.A. Nationwide

  • Dec 10, 2019
    RECALLRecall (Class III): Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-c…

    Failed Dissolution Specifications: High out of specification result observed at stability studies. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA